Atopic Dermatitis Drugs Market Size, Share & Growth Report 2032
Atopic Dermatitis Drugs Market By Therapy (Photo Therapy And Directed Therapy), By Route of Administration (Injectable, Oral, and Topical), By End-User (Hospitals, Clinics, and Research Labs), And By Region - Global Industry Perspective, Size, Trends, Comprehensive Analysis, And Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 15.19 Billion | USD 32.50 Billion | 8.94% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Atopic Dermatitis Drugs Market, 2024–2032 (USD Billion)
- 2.2. Atopic Dermatitis Drugs Market: Snapshot
- Chapter 3. Global Atopic Dermatitis Drugs Market– Industry Analysis
- 3.1. Atopic Dermatitis Drugs Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Launching of biulogic drugs to boost the product demand
- 3.2.2. Approval of the product for treating atopic dermatitis in Europe, North America, and Japan will boost the market performance
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Therapy
- 3.4.2. Market attractiveness analysis By Route of Administration
- 3.4.3. Market attractiveness analysis By End User
- 3.4.4. Market attractiveness analysis by Region
- Chapter 4. Global Atopic Dermatitis Drugs Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Atopic Dermatitis Drugs Market: company market share, 2024
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Atopic Dermatitis Drugs Market–Therapy Analysis
- 5.1. Global Atopic Dermatitis Drugs Market overview: By Therapy
- 5.1.1. Global Atopic Dermatitis Drugs Market share, By Therapy,2024 and 2032
- 5.2. Photo Therapy
- 5.2.1. Global Atopic Dermatitis Drugs Market by Photo Therapy, 2024–2032 (USD Billion)
- 5.3. Directed Therapy
- 5.3.1. Global Atopic Dermatitis Drugs Market by Directed Therapy, 2024–2032 (USD Billion)
- 5.1. Global Atopic Dermatitis Drugs Market overview: By Therapy
- Chapter 6. Global Atopic Dermatitis Drugs Market– Route of Administration Analysis
- 6.1. Global Atopic Dermatitis Drugs Market overview: By Route of Administration
- 6.1.1. Global Atopic Dermatitis Drugs Market share, By Route of Administration, 2024 and 2032
- 6.2. Injectable
- 6.2.1. Global Atopic Dermatitis Drugs Market By Injectable, 2024–2032 (USD Billion)
- 6.3. Clinics
- 6.3.1. Global Atopic Dermatitis Drugs Market By Clinics, 2024–2032 (USD Billion)
- 6.4. Research Labs
- 6.4.1. Global Atopic Dermatitis Drugs Market By Research Labs, 2024–2032 (USD Billion)
- 6.1. Global Atopic Dermatitis Drugs Market overview: By Route of Administration
- Chapter 7. Global Atopic Dermatitis Drugs Market– End User Analysis
- 7.1. Global Atopic Dermatitis Drugs Market overview: By End User
- 7.1.1. Global Atopic Dermatitis Drugs Market share, By End User, 2024 and 2032
- 7.2. Hospitals
- 7.2.1. Global Atopic Dermatitis Drugs Market By Hospitals, 2024–2032 (USD Billion)
- 7.3. Clinics
- 7.3.1. Global Atopic Dermatitis Drugs Market By Clinics, 2024–2032 (USD Billion)
- 7.4. Research Labs
- 7.4.1. Global Atopic Dermatitis Drugs Market By Research Labs, 2024–2032 (USD Billion)
- 7.1. Global Atopic Dermatitis Drugs Market overview: By End User
- Chapter 8. Company Profiles
- 8.1. Meda Pharmaceuticals
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Leo Pharma
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Bayer AG
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. Valent Pharmaceutical Inc.
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. Encore Dermatulogy
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.1. Meda Pharmaceuticals
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Atopic Dermatitis Drugs Market, 2024–2032 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Atopic Dermatitis Drugs Market attractiveness, By Therapy
6. Global Atopic Dermatitis Drugs Market attractiveness, By Route of Administration
7. Global Atopic Dermatitis Drugs Market attractiveness, By End User
8. Global Atopic Dermatitis Drugs Market attractiveness, By Therapy
9. Global Atopic Dermatitis Drugs Market share, By Therapy, 2024 and 2032
10. Global Atopic Dermatitis Drugs Market by Photo Therapy, 2024–2032 (USD Billion)
11. Global Atopic Dermatitis Drugs Market by Directed Therapy,2024–2032 (USD Billion)
12. Global Atopic Dermatitis Drugs Market Share by Route of Administration,2024 and 2032 (USD Billion)
13. Global Atopic Dermatitis Drugs Market by Injectable,2024–2032 (USD Billion)
14. Global Atopic Dermatitis Drugs Market by Oral,2024–2032 (USD Billion)
15. Global Atopic Dermatitis Drugs Market by Topical,2024–2032 (USD Billion)
16. Global Atopic Dermatitis Drugs Market Share by End User,2024 and 2032 (USD Billion)
17. Global Atopic Dermatitis Drugs Market by Hospitals,2024–2032 (USD Billion)
18. Global Atopic Dermatitis Drugs Market by Clinics,2024–2032 (USD Billion)
19. Global Atopic Dermatitis Drugs Market by Research Labs,2024–2032 (USD Billion)
20. Global Atopic Dermatitis Drugs Market share, by Region, 2024 and 2032
21. North America Atopic Dermatitis Drugs Market, 2024–2032 (USD Billion)
22. Europe Atopic Dermatitis Drugs Market, 2024–2032 (USD Billion)
23. Asia Pacific Atopic Dermatitis Drugs Market, 2024–2032 (USD Billion)
24. Latin America Atopic Dermatitis Drugs Market, 2024–2032 (USD Billion)
25. The Middle East and Africa Atopic Dermatitis Drugs Market, 2024–2032 (USD Billion)
Table Of Tables
List of Tables
1. Global Atopic Dermatitis Drugs Market: snapshot
2. Drivers of the Atopic Dermatitis Drugs Market: impact analysis
3. North America Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
4. North America Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
5. North America Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
6. The U.S. Atopic Dermatitis Drugs Market revenue, By Therapy, 2024–2032 (USD Billion)
7. The U.S. Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
8. The U.S. Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
9. Rest of North America Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
10. Rest of North America Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
11. Rest of North America Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
12. Europe Atopic Dermatitis Drugs Market revenue, By Therapy, 2024–2032 (USD Billion)
13. Europe Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
14. Europe Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
15. UK Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
16. UK Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
17. UK Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
18. France Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
19. France Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
20. France Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
21. Germany Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
22. Germany Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
23. Germany Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
24. Rest of Europe Atopic Dermatitis Drugs Market revenue, By Therapy,2024–2032 (USD Billion)
25. Rest of Europe Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
26. Rest of Europe Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
27. Asia Pacific Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
28. Asia Pacific Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
29. Asia Pacific Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
30. China Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
31. China Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
32. China Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
33. Japan Atopic Dermatitis Drugs Market revenue, By Therapy, 2024–2032 (USD Billion)
34. Japan Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
35. Japan Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
36. India Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
37. India Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
38. India Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
39. Rest of Asia Pacific Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
40. Rest of Asia Pacific Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
41. Rest of Asia Pacific Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
42. Latin America Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
43. Latin America Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
44. Latin America Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
45. Brazil Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
46. Brazil Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
47. Brazil Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
48. Rest of Latin America Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
49. Rest of Latin America Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
50. Rest of Latin America Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
51. The Middle East and Africa Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
52. The Middle East and Africa Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
53. The Middle East and Africa Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
54. Saudi Arabia Atopic Dermatitis Drugs Market revenue, By Therapy, 2024–2032 (USD Billion)
55. Saudi Arabia Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
56. Saudi Arabia Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
57. South Africa Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
58. South Africa Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
59. South Africa Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
60. Rest of the Middle East & Africa Atopic Dermatitis Drugs Market revenue, By Therapy ,2024–2032 (USD Billion)
61. Rest of the Middle East & Africa Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2024–2032 (USD Billion)
62. Rest of the Middle East & Africa Atopic Dermatitis Drugs Market Revenue, By End User, 2024–2032 (USD Billion)
Methodology
FrequentlyAsked Questions
Atopic dermatitis drugs are medications used to manage the symptoms of atopic dermatitis, also known as eczema. They can help reduce inflammation, itching, and flare-ups.
According to a study, the global atopic dermatitis drugs market size was worth around USD 15.19 billion in 2023 and is expected to reach USD 32.50 billion by 2032.
The global atopic dermatitis drugs market is expected to grow at a CAGR of 8.94% during the forecast period.
North America is expected to dominate the atopic dermatitis drugs market over the forecast period.
Leading players in the global atopic dermatitis drugs market include Meda Pharmaceuticals, Bayer AG, Encore Dermatology, Leo Pharma, and Valent Pharmaceutical Inc., among others.
The atopic dermatitis drugs market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed